Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date21 Mar 2020 |
100 Clinical Results associated with Jilin Sanjiu Jin Fu Kang Pharmaceutical Ltd.
0 Patents (Medical) associated with Jilin Sanjiu Jin Fu Kang Pharmaceutical Ltd.
100 Deals associated with Jilin Sanjiu Jin Fu Kang Pharmaceutical Ltd.
100 Translational Medicine associated with Jilin Sanjiu Jin Fu Kang Pharmaceutical Ltd.